Perspectives on sexual and reproductive health self-care among women, healthcare providers, and other key informants: a mixed-methods study in South Africa and Zambia.
Contraception
Family planning
IUD self-removal
Self-care
Sub-Saharan Africa
Journal
Reproductive health
ISSN: 1742-4755
Titre abrégé: Reprod Health
Pays: England
ID NLM: 101224380
Informations de publication
Date de publication:
28 Apr 2023
28 Apr 2023
Historique:
received:
16
07
2022
accepted:
08
03
2023
medline:
1
5
2023
pubmed:
29
4
2023
entrez:
29
4
2023
Statut:
epublish
Résumé
"Self-care" for sexual and reproductive health (SRH) includes contraceptive methods and other supplies that people can use with or without the support of a healthcare provider. Self-administered tests, self-injection of injectable contraception, or self-removal of intrauterine devices (IUDs) can increase people's access to and autonomy over their own SRH. Objectives of this study were to assess women's current interest in and use of SRH self-care and explore key informants' (KI) opinions of self-care, especially during the COVID-19 pandemic. Data for this study came from female participants in the longitudinal Contraceptive Use Beyond ECHO (CUBE) study, and KIs, including healthcare providers, in South Africa and Zambia between September 2020 and June 2021. For this analysis, we used data from a participant phone survey (n = 537), and from in-depth interviews (IDIs) completed with a sub-sample of women (n = 39) and KIs (n = 36). Survey data were analyzed with descriptive statistics, and IDI data were analyzed using applied thematic analysis. Female survey participants in South Africa were more interested in learning about emergency contraceptive pills, subcutaneous injectable contraception, and CycleBeads, while Zambian participants wanted more information and access to condoms. However, in IDIs in both countries, women described minimal experience with self-care beyond condom use. In the Zambian KI IDIs, COVID-19 led to increased self-care counseling on subcutaneous injectable contraception and HIV self-testing. KIs who do not counsel on self-care were concerned that women may harm themselves or blame the provider for difficulties. Two KIs thought that women could possibly self-remove IUDs, but most expressed concerns. Reported barriers to self-care included COVID movement restrictions, transport costs, lack of accessible pharmacies, women's low awareness, and possible stigma. Women surveyed reported interest in learning more about SRH self-care methods and resources, but in IDIs did not report extensive previous use besides condoms. KIs described some concerns about women's ability to use self-care methods. Counseling on and provision of self-care methods and supplies may have increased during the COVID-19 pandemic, but ensuring that self-care is more than just a temporary measure in health systems has the potential to increase access to SRH care and support women's autonomy and healthcare needs. “Self-care” refers to healthcare that does not have to be given by a provider, but that people can use themselves. In sexual and reproductive health (SRH), this includes medicines or supplies like pills and injections that people can use to prevent or test for pregnancy or sexually transmitted infections. This study wanted to better understand women’s interest in and use of SRH self-care and explore key informants’ opinions of self-care, especially during the COVID-19 pandemic. We surveyed 537 women in KwaZulu-Natal province, South Africa and Lusaka, Zambia in 2020–2021. We also conducted interviews with 39 women and 36 key informants, including healthcare providers, government officials, and community advocates. Women surveyed in South Africa were more interested than those in Zambia in learning more about self-care contraception, especially daily pills, emergency pills, and injections they could give themselves. In interviews, some key informants said that they do not tell women about self-care because they worried that women could hurt themselves or blame the provider if they experienced problems. COVID movement restrictions, transport costs, and inaccessible pharmacies were all barriers that key informants mentioned to accessing tests, tools, or contraceptive methods that women could give or use themselves. Women surveyed were interested in learning more about self-care and those interviewed reported minimal previous use of self-care methods besides condoms. Providers also have some concerns about women’s ability to use self-care methods. Counseling on and providing self-care methods and supplies may have increased during COVID-19, but increasing access to self-care could help more women take care of their own sexual and reproductive healthcare.
Sections du résumé
BACKGROUND
BACKGROUND
"Self-care" for sexual and reproductive health (SRH) includes contraceptive methods and other supplies that people can use with or without the support of a healthcare provider. Self-administered tests, self-injection of injectable contraception, or self-removal of intrauterine devices (IUDs) can increase people's access to and autonomy over their own SRH. Objectives of this study were to assess women's current interest in and use of SRH self-care and explore key informants' (KI) opinions of self-care, especially during the COVID-19 pandemic.
METHODS
METHODS
Data for this study came from female participants in the longitudinal Contraceptive Use Beyond ECHO (CUBE) study, and KIs, including healthcare providers, in South Africa and Zambia between September 2020 and June 2021. For this analysis, we used data from a participant phone survey (n = 537), and from in-depth interviews (IDIs) completed with a sub-sample of women (n = 39) and KIs (n = 36). Survey data were analyzed with descriptive statistics, and IDI data were analyzed using applied thematic analysis.
RESULTS
RESULTS
Female survey participants in South Africa were more interested in learning about emergency contraceptive pills, subcutaneous injectable contraception, and CycleBeads, while Zambian participants wanted more information and access to condoms. However, in IDIs in both countries, women described minimal experience with self-care beyond condom use. In the Zambian KI IDIs, COVID-19 led to increased self-care counseling on subcutaneous injectable contraception and HIV self-testing. KIs who do not counsel on self-care were concerned that women may harm themselves or blame the provider for difficulties. Two KIs thought that women could possibly self-remove IUDs, but most expressed concerns. Reported barriers to self-care included COVID movement restrictions, transport costs, lack of accessible pharmacies, women's low awareness, and possible stigma.
CONCLUSIONS
CONCLUSIONS
Women surveyed reported interest in learning more about SRH self-care methods and resources, but in IDIs did not report extensive previous use besides condoms. KIs described some concerns about women's ability to use self-care methods. Counseling on and provision of self-care methods and supplies may have increased during the COVID-19 pandemic, but ensuring that self-care is more than just a temporary measure in health systems has the potential to increase access to SRH care and support women's autonomy and healthcare needs.
BACKGROUND
BACKGROUND
“Self-care” refers to healthcare that does not have to be given by a provider, but that people can use themselves. In sexual and reproductive health (SRH), this includes medicines or supplies like pills and injections that people can use to prevent or test for pregnancy or sexually transmitted infections. This study wanted to better understand women’s interest in and use of SRH self-care and explore key informants’ opinions of self-care, especially during the COVID-19 pandemic.
METHODS
METHODS
We surveyed 537 women in KwaZulu-Natal province, South Africa and Lusaka, Zambia in 2020–2021. We also conducted interviews with 39 women and 36 key informants, including healthcare providers, government officials, and community advocates.
RESULTS
RESULTS
Women surveyed in South Africa were more interested than those in Zambia in learning more about self-care contraception, especially daily pills, emergency pills, and injections they could give themselves. In interviews, some key informants said that they do not tell women about self-care because they worried that women could hurt themselves or blame the provider if they experienced problems. COVID movement restrictions, transport costs, and inaccessible pharmacies were all barriers that key informants mentioned to accessing tests, tools, or contraceptive methods that women could give or use themselves.
CONCLUSIONS
CONCLUSIONS
Women surveyed were interested in learning more about self-care and those interviewed reported minimal previous use of self-care methods besides condoms. Providers also have some concerns about women’s ability to use self-care methods. Counseling on and providing self-care methods and supplies may have increased during COVID-19, but increasing access to self-care could help more women take care of their own sexual and reproductive healthcare.
Autres résumés
Type: plain-language-summary
(eng)
“Self-care” refers to healthcare that does not have to be given by a provider, but that people can use themselves. In sexual and reproductive health (SRH), this includes medicines or supplies like pills and injections that people can use to prevent or test for pregnancy or sexually transmitted infections. This study wanted to better understand women’s interest in and use of SRH self-care and explore key informants’ opinions of self-care, especially during the COVID-19 pandemic.
Identifiants
pubmed: 37118835
doi: 10.1186/s12978-023-01596-x
pii: 10.1186/s12978-023-01596-x
pmc: PMC10144905
doi:
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
65Subventions
Organisme : NICHD NIH HHS
ID : P2C HD050924
Pays : United States
Informations de copyright
© 2023. The Author(s).
Références
BMJ Glob Health. 2021 Jun;6(6):
pubmed: 34140304
Lancet HIV. 2018 Jun;5(6):e277-e290
pubmed: 29703707
Contracept X. 2022 May 06;4:100077
pubmed: 35620730
PLoS One. 2015 Mar 31;10(3):e0121044
pubmed: 25826246
Sex Reprod Health Matters. 2020 Dec;28(2):1778610
pubmed: 32530386
Int Q Community Health Educ. 2017 Jan;37(2):79-91
pubmed: 28056643
Contraception. 2021 Dec;104(6):654-658
pubmed: 34400154
Contraception. 2022 Feb;106:34-38
pubmed: 34752777
Contraception. 2021 Jun;103(6):377-379
pubmed: 33781763
Sex Transm Dis. 2018 Apr;45(4):272-277
pubmed: 29528987
Contraception. 2012 Mar;85(3):257-62
pubmed: 22067772
Contraception. 2020 Jun;101(6):393-398
pubmed: 32088175
S Afr Med J. 2015 Apr;105(4):266-7
pubmed: 26294863
Curr Oncol. 2022 Jan 26;29(2):516-533
pubmed: 35200547
Bull World Health Organ. 2019 Feb 1;97(2):76-76A
pubmed: 30728611
Contraception. 2014 May;89(5):368-73
pubmed: 24576792
Lancet Glob Health. 2018 May;6(5):e568-e578
pubmed: 29526707
BMJ Glob Health. 2019 Apr 22;4(2):e001349
pubmed: 31139454
BMJ Glob Health. 2019 Apr 02;4(2):e001350
pubmed: 31179026
Stud Fam Plann. 2020 Jun;51(2):161-176
pubmed: 32358789
Lancet Glob Health. 2021 Oct;9(10):e1431-e1441
pubmed: 34474001
Glob Health Sci Pract. 2022 Oct 31;10(5):
pubmed: 36316132
J Biomed Inform. 2019 Jul;95:103208
pubmed: 31078660
Contraception. 2018 Nov;98(5):405-410
pubmed: 29706227
MMWR Morb Mortal Wkly Rep. 2020 Oct 23;69(42):1547-1548
pubmed: 33090982
Contraception. 2014 Jul;90(1):54-9
pubmed: 24613370
Stud Fam Plann. 2023 Feb 1;:
pubmed: 36727169
South Afr J HIV Med. 2017 Sep 22;18(1):775
pubmed: 29568643
Contraception. 2017 Sep;96(3):203-210
pubmed: 28673645
BMC Public Health. 2013 Aug 08;13:735
pubmed: 23924387